Literature DB >> 3033928

Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines.

T W Pay, P J Hingley.   

Abstract

An analysis was made of data from potency tests on fifteen batches of monovalent foot-and-mouth disease vaccine, comprising five batches each of type O, type A and type C. Regressions were calculated for the relation of percentage protection (probit) versus log 140S antigen dose and for the serum neutralizing antibody titre (log SN50) versus log 140S antigen dose. Type O vaccines required a far higher level (220 ng) of 140S antigen to achieve a 50% protection level (PA50) in cattle than did type A (2.4 ng) and type C (4.36 ng) vaccines. Type O antigen, dose for dose, was as effective at provoking neutralizing antibody as the types A and C antigens. Thus, it would appear that a far higher log SN50 value (2.14) was required for type O vaccines to equate with 50% protection of cattle than was required for type A (1.17) and type C (1.41) vaccines. Prior to 1977, however, the PA50 value for type O vaccine strain was only 1.34 and it was concluded that an antigenic shift was the most likely cause for the large difference between that value and the current PA50 value.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033928     DOI: 10.1016/0264-410x(87)90011-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  18 in total

1.  Systemic Foot-and-Mouth Disease Vaccination in Cattle Promotes Specific Antibody-Secreting Cells at the Respiratory Tract and Triggers Local Anamnestic Responses upon Aerosol Infection.

Authors:  J Pega; S Di Giacomo; D Bucafusco; J M Schammas; D Malacari; F Barrionuevo; A V Capozzo; L L Rodríguez; M V Borca; M Pérez-Filgueira
Journal:  J Virol       Date:  2015-07-08       Impact factor: 5.103

2.  Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus.

Authors:  T R Doel; C Gale; C M Do Amaral; G Mulcahy; R Dimarchi
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

3.  Immune responses of sheep to quadrivalent double emulsion foot-and-mouth disease vaccines: rate of development of immunity and variations among other ruminants.

Authors:  Prasanna K Patil; Jagadeesh Bayry; Chitimalla Ramakrishna; Basavesh Hugar; Laxmi D Misra; Krishnamsetty Prabhudas; C Natarajan
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

4.  Comparison of test methodologies for foot-and-mouth disease virus serotype A vaccine matching.

Authors:  Tesfaalem Tekleghiorghis; Klaas Weerdmeester; Froukje van Hemert-Kluitenberg; Rob J M Moormann; Aldo Dekker
Journal:  Clin Vaccine Immunol       Date:  2014-03-12

Review 5.  Immunopotentiation and delivery systems for antigens for single-step immunization: recent trends and progress.

Authors:  M Z Khan; J P Opdebeeck; I G Tucker
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

6.  High-affinity antibody induced by immunization with a synthetic peptide is associated with protection of cattle against foot-and-mouth disease.

Authors:  M W Steward; C M Stanley; R Dimarchi; G Mulcahy; T R Doel
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

7.  Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype.

Authors:  J G Gall; R G Crystal; E Falck-Pedersen
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

8.  Structures of Foot-and-Mouth Disease Virus with Bovine Neutralizing Antibodies Reveal the Determinant of Intraserotype Cross-Neutralization.

Authors:  Yong He; Kun Li; Li Wang; Zixian Sun; Yimei Cao; Pinghua Li; Pu Sun; Huifang Bao; Shasha Zhou; Sheng Wang; Xingwen Bai; Xuerong Liu; Lixia Zhao; Xiuli Fan; Zaixin Liu; Zengjun Lu; Cheng Yang; Zhiyong Lou
Journal:  J Virol       Date:  2021-09-29       Impact factor: 5.103

9.  Determining the epitope dominance on the capsid of a serotype SAT2 foot-and-mouth disease virus by mutational analyses.

Authors:  Pamela A Opperman; Lia S Rotherham; Jan Esterhuysen; Bryan Charleston; Nicholas Juleff; Alejandra V Capozzo; Jacques Theron; Francois F Maree
Journal:  J Virol       Date:  2014-05-14       Impact factor: 5.103

10.  Novel antibody binding determinants on the capsid surface of serotype O foot-and-mouth disease virus.

Authors:  Amin S Asfor; Sasmita Upadhyaya; Nick J Knowles; Donald P King; David J Paton; Mana Mahapatra
Journal:  J Gen Virol       Date:  2014-02-28       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.